DYRK1A Inhibitors as Potential Therapeutics for β-Cell Regeneration for Diabetes
-
- Kunal Kumar
- Drug Discovery Institute and Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York 10029, United States
-
- Chalada Suebsuwong
- Drug Discovery Institute and Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York 10029, United States
-
- Peng Wang
- Diabetes, Obesity, and Metabolism Institute, Icahn School of Medicine at Mount Sinai, New York, New York 10029, United States
-
- Adolfo Garcia-Ocana
- Diabetes, Obesity, and Metabolism Institute, Icahn School of Medicine at Mount Sinai, New York, New York 10029, United States
-
- Andrew F. Stewart
- Diabetes, Obesity, and Metabolism Institute, Icahn School of Medicine at Mount Sinai, New York, New York 10029, United States
-
- Robert J. DeVita
- Drug Discovery Institute and Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York 10029, United States
Journal
-
- Journal of Medicinal Chemistry
-
Journal of Medicinal Chemistry 64 (6), 2901-2922, 2021-03-08
American Chemical Society (ACS)
- Tweet
Details 詳細情報について
-
- CRID
- 1360013171987985024
-
- ISSN
- 15204804
- 00222623
-
- Data Source
-
- Crossref